Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Parent Drug and Active Metabolite (FDA) [Regulatives / Guidelines]

posted by joyjac – Philippines, 2006-05-10 07:44 (7330 d 02:34 ago) – Posting: # 122
Views: 11,560

Dear HS,

Just to clarify in case of (2): 90% CI will be applied to the parent drug and present the metabolite data descriptively - would this mean that ANOVA on the metabolite data is not necessary?

Thanks for sharing your expertise.
Joy

Complete thread:

Parent Drug and Active Metabolite joyjac 2006-05-09 07:45 [Regulatives / Guidelines]
- Parent Drug and Active Metabolite (FDA) Helmut 2006-05-09 11:34
  - Parent Drug and Active Metabolite (FDA)joyjac 2006-05-10 05:44
    - Parent Drug and Active Metabolite (FDA) Helmut 2006-05-10 08:22

Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
211 visitors (0 registered, 211 guests [including 26 identified bots]).
Forum time: 10:19 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius. Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz